Tobias Joseph D, Berkenbosch John W, Russo Pierantonio
Department of Child Health, University of Missouri, Columbia, MO 65212, USA.
South Med J. 2003 Sep;96(9):871-5. doi: 10.1097/01.SMJ.0000053557.75799.09.
This study evaluates the efficacy of dexmedetomidine in clinical scenarios other than sedation during mechanical ventilation.
We conducted a retrospective chart review and presentation of case series of children in the pediatric intensive care unit and the postanesthesia care unit who received dexmedetomidine.
Dexmedetomidine was administered by continuous infusion to three patients and as a single bolus dose (0.5 microg/kg) to two patients. In the five clinical scenarios, dexmedetomidine provided effective sedation during spontaneous ventilation in two patients, reversed the clinical signs and symptoms of withdrawal from illicit substances in one patient, and was effective in the treatment of postanesthesia emergence delirium and shivering in two additional patients.
These preliminary data suggest that dexmedetomidine may be an effective agent for sedation in spontaneously breathing patients, in the treatment of drug withdrawal, and in the treatment of two common postanesthesia problems.
本研究评估右美托咪定在机械通气期间镇静以外的临床场景中的疗效。
我们对儿科重症监护病房和麻醉后护理病房中接受右美托咪定治疗的儿童进行了回顾性病历审查并呈现病例系列。
3例患者接受右美托咪定持续输注,2例患者接受单次推注剂量(0.5微克/千克)。在这5种临床场景中,右美托咪定在2例患者的自主通气期间提供了有效的镇静作用,在1例患者中逆转了非法物质戒断的临床体征和症状,在另外2例患者中对麻醉后苏醒期谵妄和寒战的治疗有效。
这些初步数据表明,右美托咪定可能是自主呼吸患者镇静、药物戒断治疗以及两种常见麻醉后问题治疗的有效药物。